Patents by Inventor Udi Vazana

Udi Vazana has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of transcranial magnetic stimulation to modulate permeability of the blood-brain barrier
    Patent number: 11241584
    Abstract: Transcranial magnetic stimulation (TMS) is used to modulate permeability of the blood brain barrier in a transient, safe and non-invasive manner. A conventional or deep TMS coil may be placed on a head in a vicinity of a tumor, for example. A series of magnetic pulses is provided to the brain with a tailored stimulation protocol. In one of many possible clinical applications, a pharmaceutical substance may be introduced during a time frame before, during or after providing the magnetic pulses to treat a tumor in the brain.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: February 8, 2022
    Assignee: BRAINSWAY, LTD.
    Inventors: Gaby Pell, Abraham Zangen, Yiftach Roth, Alon Friedman, Udi Vazana
  • USE OF TRANSCRANIAL MAGNETIC STIMULATION TO MODULATE PERMEABILITY OF THE BLOOD-BRAIN BARRIER
    Publication number: 20190388697
    Abstract: Transcranial magnetic stimulation (TMS) is used to modulate permeability of the blood brain barrier in a transient, safe and non-invasive manner. A conventional or deep TMS coil may be placed on a head in a vicinity of a tumor, for example. A series of magnetic pulses is provided to the brain with a tailored stimulation protocol. In one of many possible clinical applications, a pharmaceutical substance may be introduced during a time frame before, during or after providing the magnetic pulses to treat a tumor in the brain.
    Type: Application
    Filed: July 2, 2019
    Publication date: December 26, 2019
    Inventors: GABY PELL, ABRAHAM ZANGEN, YIFTACH ROTH, ALON FRIEDMAN, UDI VAZANA
  • Use of transcranial magnetic stimulation to modulate permeability of the blood-brain barrier
    Patent number: 10335606
    Abstract: Transcranial magnetic stimulation (TMS) is used to modulate permeability of the blood brain barrier in a transient, safe and non-invasive manner. A conventional or deep TMS coil may be placed on a head in a vicinity of a tumor, for example. A series of magnetic pulses is provided to the brain with a tailored stimulation protocol. In one of many possible clinical applications, a pharmaceutical substance may be introduced during a time frame before, during or after providing the magnetic pulses to treat a tumor in the brain.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: July 2, 2019
    Assignee: BRAINSWAY, LTD.
    Inventors: Gaby Pell, Abraham Zangen, Yiftach Roth, Alon Friedman, Udi Vazana
  • USE OF TRANSCRANIAL MAGNETIC STIMULATION TO MODULATE PERMEABILITY OF THE BLOOD-BRAIN BARRIER
    Publication number: 20170291036
    Abstract: Transcranial magnetic stimulation (TMS) is used to modulate permeability of the blood brain barrier in a transient, safe and non-invasive manner. A conventional or deep TMS coil may be placed on a head in a vicinity of a tumor, for example. A series of magnetic pulses is provided to the brain with a tailored stimulation protocol. In one of many possible clinical applications, a pharmaceutical substance may be introduced during a time frame before, during or after providing the magnetic pulses to treat a tumor in the brain.
    Type: Application
    Filed: April 27, 2017
    Publication date: October 12, 2017
    Inventors: GABY PELL, ABRAHAM ZANGEN, YIFTACH ROTH, ALON FRIEDMAN, UDI VAZANA
  • Use of transcranial magnetic stimulation to modulate permeability of the blood-brain barrier
    Patent number: 9636517
    Abstract: Transcranial magnetic stimulation (TMS) is used to modulate permeability of the blood brain barrier in a transient, safe and non-invasive manner. A conventional or deep TMS coil may be placed on a head in a vicinity of a tumor, for example. A series of magnetic pulses is provided to the brain with a tailored stimulation protocol. In one of many possible clinical applications, a pharmaceutical substance may be introduced during a time frame before, during or after providing the magnetic pulses to treat a tumor in the brain.
    Type: Grant
    Filed: February 13, 2013
    Date of Patent: May 2, 2017
    Assignee: Brainsway, Ltd.
    Inventors: Gaby Pell, Abraham Zangen, Yiftach Roth, Alon Friedman, Udi Vazana